Press Release

Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
CGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapiesCGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapiesCGT Catapult to take part in consortium aiming to improve the sustainability of CAR-T manufacturingCGT Catapult to take part in consortium aiming to improve the sustainability of CAR-T manufacturingCGT Catapult annual review highlights the role of advanced therapies in supporting Government ambitions for public health and economic growthCGT Catapult annual review highlights the role of advanced therapies in supporting Government ambitions for public health and economic growthNew evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economyNew evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economyUnderstanding life with Beta ThalassemiaUnderstanding life with Beta ThalassemiaCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsMHRA introduces regulations that allow decentralised manufacturing of therapiesMHRA introduces regulations that allow decentralised manufacturing of therapiesCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Ed Samuel as Chief Operating OfficerCell and Gene Therapy Catapult appoints Dr Ed Samuel as Chief Operating OfficerSpliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotSpliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotCGT Catapult response to publication of the Life Sciences Sector PlanCGT Catapult response to publication of the Life Sciences Sector PlanCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platform